ID   ACATN_HUMAN             Reviewed;         549 AA.
AC   O00400; B2R5Q2; D3DNK4;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   10-MAY-2017, entry version 131.
DE   RecName: Full=Acetyl-coenzyme A transporter 1;
DE            Short=AT-1;
DE            Short=Acetyl-CoA transporter 1;
DE   AltName: Full=Solute carrier family 33 member 1;
GN   Name=SLC33A1; Synonyms=ACATN, AT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Melanoma;
RX   PubMed=9096318; DOI=10.1073/pnas.94.7.2897;
RA   Kanamori A., Nakayama J., Fukuda M.N., Stallcup W.B., Sasaki K.,
RA   Fukuda M., Hirabayashi Y.;
RT   "Expression cloning and characterization of a cDNA encoding a novel
RT   membrane protein required for the formation of O-acetylated
RT   gangliosides: a putative acetyl CoA transporter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:2897-2902(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6]
RP   FUNCTION, VARIANT SPG42 ARG-113, AND CHARACTERIZATION OF VARIANT SPG42
RP   ARG-113.
RX   PubMed=25402622; DOI=10.1002/humu.22732;
RA   Mao F., Li Z., Zhao B., Lin P., Liu P., Zhai M., Liu Q., Shao C.,
RA   Sun W., Gong Y.;
RT   "Identification and Functional Analysis of a SLC33A1: c.339T>G
RT   (p.Ser113Arg) Variant in the Original SPG42 Family.";
RL   Hum. Mutat. 36:240-249(2015).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-400.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [9]
RP   VARIANT SPG42 ARG-113.
RX   PubMed=19061983; DOI=10.1016/j.ajhg.2008.11.003;
RA   Lin P., Li J., Liu Q., Mao F., Li J., Qiu R., Hu H., Song Y., Yang Y.,
RA   Gao G., Yan C., Yang W., Shao C., Gong Y.;
RT   "A missense mutation in SLC33A1, which encodes the acetyl-CoA
RT   transporter, causes autosomal-dominant spastic paraplegia (SPG42).";
RL   Am. J. Hum. Genet. 83:752-759(2008).
RN   [10]
RP   VARIANT CCHLND PRO-110, AND CHARACTERIZATION OF VARIANT CCHLND
RP   PRO-110.
RX   PubMed=22243965; DOI=10.1016/j.ajhg.2011.11.030;
RA   Huppke P., Brendel C., Kalscheuer V., Korenke G.C., Marquardt I.,
RA   Freisinger P., Christodoulou J., Hillebrand M., Pitelet G., Wilson C.,
RA   Gruber-Sedlmayr U., Ullmann R., Haas S., Elpeleg O., Nurnberg G.,
RA   Nurnberg P., Dad S., Moller L.B., Kaler S.G., Gartner J.;
RT   "Mutations in SLC33A1 cause a lethal autosomal-recessive disorder with
RT   congenital cataracts, hearing loss, and low serum copper and
RT   ceruloplasmin.";
RL   Am. J. Hum. Genet. 90:61-68(2012).
RN   [11]
RP   ERRATUM.
RA   Huppke P., Brendel C., Kalscheuer V., Korenke G.C., Marquardt I.,
RA   Freisinger P., Christodoulou J., Hillebrand M., Pitelet G., Wilson C.,
RA   Gruber-Sedlmayr U., Ullmann R., Haas S., Elpeleg O., Nurnberg G.,
RA   Nurnberg P., Dad S., Moller L.B., Kaler S.G., Gartner J.;
RL   Am. J. Hum. Genet. 90:378-378(2012).
CC   -!- FUNCTION: Probable acetyl-CoA transporter necessary for O-
CC       acetylation of gangliosides (PubMed:9096318). Negatively regulates
CC       BMP signaling (PubMed:25402622). {ECO:0000269|PubMed:25402622,
CC       ECO:0000269|PubMed:9096318}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:9096318}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:9096318}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Detected in heart, brain,
CC       placenta, lung, liver, skeletal muscle, kidney and pancreas. With
CC       strongest signals in pancreas. {ECO:0000269|PubMed:9096318}.
CC   -!- DISEASE: Spastic paraplegia 42, autosomal dominant (SPG42)
CC       [MIM:612539]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness
CC       and spasticity of the lower limbs. Rate of progression and the
CC       severity of symptoms are quite variable. Initial symptoms may
CC       include difficulty with balance, weakness and stiffness in the
CC       legs, muscle spasms, and dragging the toes when walking. In some
CC       forms of the disorder, bladder symptoms (such as incontinence) may
CC       appear, or the weakness and stiffness may spread to other parts of
CC       the body. {ECO:0000269|PubMed:19061983,
CC       ECO:0000269|PubMed:25402622}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Congenital cataracts, hearing loss, and neurodegeneration
CC       (CCHLND) [MIM:614482]: An autosomal recessive disorder
CC       characterized by congenital cataracts, severe psychomotor
CC       retardation, and hearing loss associated with decreased serum
CC       ceruloplasmin and copper. Brain MRI shows cerebral and cerebellar
CC       atrophy and hypomyelination. {ECO:0000269|PubMed:22243965}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the SLC33A transporter family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mendelian genes solute carrier family 33
CC       (acetyl-CoA transporter), member 1 (SLC33A1); Note=Leiden Open
CC       Variation Database (LOVD);
CC       URL="http://www.lovd.nl/SLC33A1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D88152; BAA20072.1; -; mRNA.
DR   EMBL; AK312268; BAG35199.1; -; mRNA.
DR   EMBL; CH471052; EAW78743.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78744.1; -; Genomic_DNA.
DR   EMBL; BC014416; AAH14416.1; -; mRNA.
DR   CCDS; CCDS3173.1; -.
DR   RefSeq; NP_001177921.1; NM_001190992.1.
DR   RefSeq; NP_004724.1; NM_004733.3.
DR   UniGene; Hs.478031; -.
DR   ProteinModelPortal; O00400; -.
DR   BioGrid; 114632; 58.
DR   IntAct; O00400; 58.
DR   STRING; 9606.ENSP00000352456; -.
DR   BindingDB; O00400; -.
DR   ChEMBL; CHEMBL3638338; -.
DR   TCDB; 2.A.1.25.1; the major facilitator superfamily (mfs).
DR   iPTMnet; O00400; -.
DR   PhosphoSitePlus; O00400; -.
DR   BioMuta; SLC33A1; -.
DR   EPD; O00400; -.
DR   MaxQB; O00400; -.
DR   PaxDb; O00400; -.
DR   PeptideAtlas; O00400; -.
DR   PRIDE; O00400; -.
DR   DNASU; 9197; -.
DR   Ensembl; ENST00000359479; ENSP00000352456; ENSG00000169359.
DR   Ensembl; ENST00000392845; ENSP00000376587; ENSG00000169359.
DR   GeneID; 9197; -.
DR   KEGG; hsa:9197; -.
DR   UCSC; uc003fan.6; human.
DR   CTD; 9197; -.
DR   DisGeNET; 9197; -.
DR   GeneCards; SLC33A1; -.
DR   HGNC; HGNC:95; SLC33A1.
DR   HPA; HPA042430; -.
DR   HPA; HPA060345; -.
DR   MalaCards; SLC33A1; -.
DR   MIM; 603690; gene.
DR   MIM; 612539; phenotype.
DR   MIM; 614482; phenotype.
DR   neXtProt; NX_O00400; -.
DR   OpenTargets; ENSG00000169359; -.
DR   Orphanet; 171863; Autosomal dominant spastic paraplegia type 42.
DR   Orphanet; 300313; Congenital cataract-hearing loss-severe developmental delay syndrome.
DR   PharmGKB; PA24432; -.
DR   eggNOG; KOG3574; Eukaryota.
DR   eggNOG; COG0477; LUCA.
DR   GeneTree; ENSGT00730000111115; -.
DR   HOGENOM; HOG000194770; -.
DR   HOVERGEN; HBG052723; -.
DR   InParanoid; O00400; -.
DR   KO; K03372; -.
DR   OMA; LWFWGIT; -.
DR   OrthoDB; EOG091G06Y7; -.
DR   PhylomeDB; O00400; -.
DR   TreeFam; TF300008; -.
DR   Reactome; R-HSA-425397; Transport of vitamins, nucleosides, and related molecules.
DR   ChiTaRS; SLC33A1; human.
DR   GenomeRNAi; 9197; -.
DR   PRO; PR:O00400; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000169359; -.
DR   CleanEx; HS_SLC33A1; -.
DR   ExpressionAtlas; O00400; baseline and differential.
DR   Genevisible; O00400; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:ProtInc.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008521; F:acetyl-CoA transporter activity; TAS:Reactome.
DR   GO; GO:0015295; F:solute:proton symporter activity; IBA:GO_Central.
DR   GO; GO:0030509; P:BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR024371; Acetyl-CoA_trnpstr_1.
DR   InterPro; IPR004752; AmpG_permease/AT-1.
DR   InterPro; IPR020846; MFS_dom.
DR   Pfam; PF13000; Acatn; 2.
DR   SUPFAM; SSF103473; SSF103473; 2.
DR   TIGRFAMs; TIGR00901; 2A0125; 1.
PE   1: Evidence at protein level;
KW   Cataract; Complete proteome; Deafness; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Hereditary spastic paraplegia;
KW   Membrane; Neurodegeneration; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    549       Acetyl-coenzyme A transporter 1.
FT                                /FTId=PRO_0000076165.
FT   TOPO_DOM      1     74       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     75     95       Helical. {ECO:0000255}.
FT   TOPO_DOM     96    113       Extracellular. {ECO:0000255}.
FT   TRANSMEM    114    134       Helical. {ECO:0000255}.
FT   TOPO_DOM    135    141       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TOPO_DOM    163    175       Extracellular. {ECO:0000255}.
FT   TRANSMEM    176    196       Helical. {ECO:0000255}.
FT   TOPO_DOM    197    217       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical. {ECO:0000255}.
FT   TOPO_DOM    239    256       Extracellular. {ECO:0000255}.
FT   TRANSMEM    257    277       Helical. {ECO:0000255}.
FT   TOPO_DOM    278    299       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    300    320       Helical. {ECO:0000255}.
FT   TOPO_DOM    321    343       Extracellular. {ECO:0000255}.
FT   TRANSMEM    344    364       Helical. {ECO:0000255}.
FT   TOPO_DOM    365    378       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    379    398       Helical. {ECO:0000255}.
FT   TOPO_DOM    399    404       Extracellular. {ECO:0000255}.
FT   TRANSMEM    405    425       Helical. {ECO:0000255}.
FT   TOPO_DOM    426    508       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    509    529       Helical. {ECO:0000255}.
FT   TOPO_DOM    530    549       Extracellular. {ECO:0000255}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      42     42       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99J27}.
FT   CARBOHYD    103    103       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     110    110       A -> P (in CCHLND; the mutant protein is
FT                                present at normal levels in patient
FT                                fibroblasts; the mutant protein fails to
FT                                localize normally to the Golgi apparatus
FT                                and instead shows punctate staining in
FT                                the cytoplasm; dbSNP:rs281875283).
FT                                {ECO:0000269|PubMed:22243965}.
FT                                /FTId=VAR_067915.
FT   VARIANT     113    113       S -> R (in SPG42; significant increase in
FT                                the amount of nuclear phosphorylated
FT                                SMAD1-SMAD5-SMAD8 protein complex; marked
FT                                increase of the BMPR1A protein level; no
FT                                change for BMPR2 protein level; decrease
FT                                of BMPR1A degradation;
FT                                dbSNP:rs121909484).
FT                                {ECO:0000269|PubMed:19061983,
FT                                ECO:0000269|PubMed:25402622}.
FT                                /FTId=VAR_054850.
FT   VARIANT     171    171       D -> G (in dbSNP:rs3804769).
FT                                /FTId=VAR_050631.
FT   VARIANT     400    400       V -> A (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035776.
SQ   SEQUENCE   549 AA;  60909 MW;  ABDE59DEDEBAA9A5 CRC64;
     MSPTISHKDS SRQRRPGNFS HSLDMKSGPL PPGGWDDSHL DSAGREGDRE ALLGDTGTGD
     FLKAPQSFRA ELSSILLLLF LYVLQGIPLG LAGSIPLILQ SKNVSYTDQA FFSFVFWPFS
     LKLLWAPLVD AVYVKNFGRR KSWLVPTQYI LGLFMIYLST QVDRLLGNTD DRTPDVIALT
     VAFFLFEFLA ATQDIAVDGW ALTMLSRENV GYASTCNSVG QTAGYFLGNV LFLALESADF
     CNKYLRFQPQ PRGIVTLSDF LFFWGTVFLI TTTLVALLKK ENEVSVVKEE TQGITDTYKL
     LFAIIKMPAV LTFCLLILTA KIGFSAADAV TGLKLVEEGV PKEHLALLAV PMVPLQIILP
     LIISKYTAGP QPLNTFYKAM PYRLLLGLEY ALLVWWTPKV EHQGGFPIYY YIVVLLSYAL
     HQVTVYSMYV SIMAFNAKVS DPLIGGTYMT LLNTVSNLGG NWPSTVALWL VDPLTVKECV
     GASNQNCRTP DAVELCKKLG GSCVTALDGY YVESIICVFI GFGWWFFLGP KFKKLQDEGS
     SSWKCKRNN
//
